Veronica Chen, PhD Rac
About Veronica Chen, PhD Rac
Veronica Chen, PhD, is the Senior Director of Global Regulatory Affairs, Oncology at BeiGene, with over 10 years of experience in oncology clinical development and global regulatory affairs.
Title
Veronica Chen holds the position of Senior Director, Global Regulatory Affairs, Oncology at BeiGene. In this role, she leads strategic regulatory activities and oversees the regulatory compliance of oncology products on a global scale.
Company
Veronica Chen is currently employed at BeiGene, a global biotechnology company focused on molecularly-targeted and immuno-oncology drug development. Her work involves addressing complex regulatory challenges and ensuring the successful approval and compliance of oncology treatments.
Background
Veronica Chen has an extensive background in global regulatory affairs and oncology clinical development, with over a decade of experience in the pharmaceutical industry. She has held various pivotal roles at Merck, Bayer Pharmaceuticals, Novartis, and Aleon Pharma International, Inc. Her responsibilities have included overseeing regulatory strategies and managing clinical trials for oncology products at different stages of development.
Education and Expertise
Veronica Chen received her PhD from the University of Dundee. Her expertise includes clinical trial design and management, and regulatory data analysis for global filings such as NDAs and BLAs. She is adept in not only conforming to compliance standards but also in strategically navigating the complex regulatory landscape to achieve successful outcomes.
Achievements
Throughout her career, Veronica Chen has led strategic regulatory activities resulting in successful product approvals. She is committed to mentoring and developing her team, utilizing her deep knowledge and analytical skills to advocate for effective and compliant oncology therapies. She has consistently demonstrated her ability to handle intricate regulatory tasks and to support clinical development with precision and insight.